Peter Zdziarski: Standing Together for Ultra Rare Bleeding Disorders Awareness Day
Peter Zdziarski, Founder and Marketing Director of Glanzmann Thrombasthenia Advocacy Network, shared a post on LinkedIn:
“Today I recognize Ultra Rare Bleeding Disorders Awareness Day.
For those living with conditions like Glanzmann Thrombasthenia, the journey can sometimes feel isolating.
But no matter how rare your condition is or how alone you may feel, there is always someone else in the world who understands exactly what you are going through.
The GT Support Group connects nearly a thousand patients, families, caregivers, and physicians from around the world who share experiences, offer guidance, and help answer questions when support is needed most.
The collage in this image represents just a small glimpse of this global community.
Behind every photo is a story, a family, and a reminder that even the rarest conditions become stronger when we stand together.
Share or join our group today.”
More posts featuring Peter Zdziarski on Hemostasis Today.
-
Sep 9, 2026, 17:57CRISPR/Cas Gene Editing in β-Thalassemia: From Molecular Correction to Clinical Reality
-
Sep 9, 2026, 17:38Cardiovascular Health in Bleeding Disorders – EHC
-
Sep 9, 2026, 17:33Manasvi Shah: Co-Inheritance of Alpha Globin Gene Multiplication With Beta Globin Gene Abnormalities
-
Sep 9, 2026, 17:29Christina Crossette-Thambiah: One of the Largest Studies to Date in Antiphospholipid Syndrome
-
Sep 9, 2026, 17:25Alan Nurden: A miR-146a Variant Reveals a New Pathway Linking Platelet Metabolism and Thrombosis
-
Sep 9, 2026, 17:17When Is Thrombophilia Testing Appropriate and How Can the Evidence Guide Clinical Care? – ISTH
-
Sep 9, 2026, 16:07Zahra Safarzadeh: From Novel F8 Variant to Clinical Significance
-
Sep 9, 2026, 16:00Maximo Agustin Schiavone: HDL Beyond Cholesterol – Linking Lipids and Immunity
-
Sep 9, 2026, 15:56Abdul Mannan: When Antiseizure Drugs Alter DOAC Risk